The inhibition of the uptake of monoamines by blood platelets by phenothiazines and other drugs.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001679:Biogenic Amines / Q000037:antagonists & inhibitors* / Q000097:blood; D001792:Blood Platelets / Q000166:cytology / Q000378:metabolism*; D002250:Carbon Radioisotopes; D002462:Cell Membrane / Q000378:metabolism; D003042:Cocaine / Q000494:pharmacology; D003864:Depression, Chemical; D003984:Dibenzazepines / Q000494:pharmacology; D004298:Dopamine / Q000097:blood; D006461:Hemolysis / Q000187:drug effects; D066298:In Vitro Techniques; D008680:Metaraminol / Q000097:blood; D008691:Methadone / Q000494:pharmacology; D008745:Methylation; D009020:Morphine / Q000494:pharmacology; D010640:Phenothiazines / Q000494:pharmacology*; D012701:Serotonin / Q000097:blood; D013329:Structure-Activity Relationship; D013500:Surface Tension; D014316:Tritium
D000928:Antidepressive Agents; D001679:Biogenic Amines; D002250:Carbon Radioisotopes; D003984:Dibenzazepines; D010640:Phenothiazines; D014316:Tritium; D012701:Serotonin; D009020:Morphine; D001285:Atropine; D008680:Metaraminol; D003042:Cocaine; D008691:Methadone; D004298:Dopamine